When the inhibitory immune checkpoint PD-1 expressed by some kinds of immune cells such as CD8+ T cells and (or) its corresponding ligand PD-L1 expressed by tumor cells are blocked, the exhaustion of T cells will be impaired, and the immune system will be enhanced (50–52). This evidence concerns the gene CD8A and neoplasm.